Logo-bi
Original Research

1. Nafion-coated cadmium pentacyanonitrosylferrate-modified glassy carbon electrode for detection of dopamine in biological samples
Mohammad Johari-Ahar, Jaleh Barar* ORCID, Pari Karami, Davoud Asgari, Soodabeh Davaran, Mohammad-Reza Rashidi*
Bioimpacts. 2018;8(4): 263-270. doi: 10.15171/bi.2018.29
PMCID: PMC6209831     PMID: 30397581     Scopus ID: 85056094508    
Article
PDF
Suppl 1
Full Text
XML
Cited By:
5
1
5
Original Research

2. Preparation and Characterization of a Novel Smart Polymeric Hydrogel for Drug Delivery of Insulin
Behzad Jafari, Farzaneh Rafie, Soodabeh Davaran*
Bioimpacts. 2011;1(2): 135-143. doi: 10.5681/bi.2011.018
PMCID: PMC3648951     PMID: 23678418     Scopus ID: 84872944287    
Article
PDF
XML
Cited By:
29
4
0
Original Article

3. PCL-based nanoparticles for doxorubicin-ezetimibe co-delivery: A combination therapy for prostate cancer using a drug repurposing strategy
Mina Yousefnezhad, Soodabeh Davaran* ORCID, Mirzaagha Babazadeh, Abolfazl Akbarzadeh, Hamidreza Pazoki-Toroudi
Bioimpacts. 2023;13(3): 241-253. doi: 10.34172/bi.2023.24252
PMCID: PMC10329752     PMID: 37431480     Scopus ID: 85157052599    
Article
PDF
Full Text
XML
Cited By:
10
0
4
Drug repurposing is an effective strategy for identifying and using approved drugs for new therapeutic purposes. We investigated co-delivery of the antitumor drugs, doxorubicin (DOX), and ezetimibe (EZ) as a cholesterol uptake-blocking drug with PCEC on prostate cancer cell line (PC3).
Original Article

4. Synthesis and characterization of a magnetic bacterial cellulose-chitosan nanocomposite and evaluation of its applicability for osteogenesis
Nahid Rezazadeh ORCID, Effat Alizadeh, Somaieh Soltani, Soodabeh Davaran* ORCID, Neda Esfandiari* ORCID
Bioimpacts. 2024;14(6): 30159. doi: 10.34172/bi.2024.30159
PMCID: PMC11530965     PMID: 39493895     Scopus ID: 85196320454    
Article
PDF
Full Text
XML
Cited By:
1
0
1

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons